Matches in Nanopublications for { ?s ?p "[As previous studies demonstrated both an increase in PGE2 synthesis and an up-regulation of COX-2 and iNOS mRNA by ischemia-reperfusion injury in the model (Braun and Kietzmann, 2004), inhibitory effects of the glucocorticoid dexamethasone, the NSAID flunixin and the selective COX-2 inhibitor DFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2-(5H)-furanone) were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_assertion description "[As previous studies demonstrated both an increase in PGE2 synthesis and an up-regulation of COX-2 and iNOS mRNA by ischemia-reperfusion injury in the model (Braun and Kietzmann, 2004), inhibitory effects of the glucocorticoid dexamethasone, the NSAID flunixin and the selective COX-2 inhibitor DFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2-(5H)-furanone) were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454211.RAa-QcWuiYArfQ8zKgtjYCt-uo5XMmTaefI8Xdd5QvVgA130_provenance.
- NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_assertion description "[As previous studies demonstrated both an increase in PGE2 synthesis and an up-regulation of COX-2 and iNOS mRNA by ischemia-reperfusion injury in the model (Braun and Kietzmann, 2004), inhibitory effects of the glucocorticoid dexamethasone, the NSAID flunixin and the selective COX-2 inhibitor DFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2-(5H)-furanone) were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_provenance.
- NP915411.RAM-Rw7e_6_iXfw3zkomhvCStyMQTngd5DNDJKKBhgoQA130_assertion description "[As previous studies demonstrated both an increase in PGE2 synthesis and an up-regulation of COX-2 and iNOS mRNA by ischemia-reperfusion injury in the model (Braun and Kietzmann, 2004), inhibitory effects of the glucocorticoid dexamethasone, the NSAID flunixin and the selective COX-2 inhibitor DFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2-(5H)-furanone) were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915411.RAM-Rw7e_6_iXfw3zkomhvCStyMQTngd5DNDJKKBhgoQA130_provenance.
- NP573211.RA77HLdzx2z39XFX07DQ42WxZHaTwJrnoolHEihegb8XM130_assertion description "[As previous studies demonstrated both an increase in PGE2 synthesis and an up-regulation of COX-2 and iNOS mRNA by ischemia-reperfusion injury in the model (Braun and Kietzmann, 2004), inhibitory effects of the glucocorticoid dexamethasone, the NSAID flunixin and the selective COX-2 inhibitor DFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2-(5H)-furanone) were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573211.RA77HLdzx2z39XFX07DQ42WxZHaTwJrnoolHEihegb8XM130_provenance.
- NP657252.RA_knwTfrog6lw9svYPxHeQrTKxoz3b-eSqLd35QqIIkw130_assertion description "[As previous studies demonstrated both an increase in PGE2 synthesis and an up-regulation of COX-2 and iNOS mRNA by ischemia-reperfusion injury in the model (Braun and Kietzmann, 2004), inhibitory effects of the glucocorticoid dexamethasone, the NSAID flunixin and the selective COX-2 inhibitor DFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2-(5H)-furanone) were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657252.RA_knwTfrog6lw9svYPxHeQrTKxoz3b-eSqLd35QqIIkw130_provenance.
- NP438000.RAwjfgKF9vR5CH3A5Gej8RRWV6ys0Gc6gfSnG-zz-rI3s130_assertion description "[As previous studies demonstrated both an increase in PGE2 synthesis and an up-regulation of COX-2 and iNOS mRNA by ischemia-reperfusion injury in the model (Braun and Kietzmann, 2004), inhibitory effects of the glucocorticoid dexamethasone, the NSAID flunixin and the selective COX-2 inhibitor DFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2-(5H)-furanone) were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438000.RAwjfgKF9vR5CH3A5Gej8RRWV6ys0Gc6gfSnG-zz-rI3s130_provenance.